Sensitivity determination marker for anti-cancer drugs in combination with 3 drugs

摘要

An anticancer drug sensitivity determination marker capable of discriminating treatment responsiveness of an individual patient and a new cancer treatment means using the same. Oxaliplatin or a salt thereof and fluorouracil or a salt thereof and levophorate or a salt thereof, comprising one or more genes selected from ALAD gene, C20orf43 gene, CBLES1 gene, CDC14B gene, GDA gene, HOXB6 gene, RPL7AP27 gene, TMEM18 gene and UGT2B10 gene Sensitivity marker for anticancer drugs including salt.